Auxly Cannabis Group Inc
OTC:CBWTF
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.034
0.131
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
ROE
Return on Equity (ROE) measures how effectively a company generates profit from shareholders` equity. It shows how much net income is earned for each dollar invested by shareholders.
Return on Equity (ROE) measures how effectively a company generates profit from shareholders` equity. It shows how much net income is earned for each dollar invested by shareholders.
Peer Comparison
| Country | Company | Market Cap | ROE | ||
|---|---|---|---|---|---|
| CA |
|
Auxly Cannabis Group Inc
TSX:XLY
|
188.8m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
954.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
546.2B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
269.6B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
208B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
217.7B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
265.4B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147.6B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
93.9B EUR |
Loading...
|
Market Distribution
| Min | -111 866% |
| 30th Percentile | -21.1% |
| Median | -0.5% |
| 70th Percentile | 11.3% |
| Max | 3 553 600% |
Other Profitability Ratios
Auxly Cannabis Group Inc
Glance View
Auxly Cannabis Group, Inc. engages in developing, manufacturing, and distributing branded cannabis products for wellness and recreational consumers. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-08-20. The firm is focused on developing, manufacturing and distributing branded cannabis products for wellness and recreational consumers. The firm's segments include Canadian cannabis operations and South American cannabis operations. Both segments are engaged in the cultivation and sale of cannabis products in respective regions. The company provides various products, including vaporizers, edibles, pre-rolls, capsules and oils and concentrates. The firm's brands include Back Forty, Foray, Dosecann and Kolab Project. The company is also a licensed producer of Cannabis 2.0 as well as Cannabis 1.0 products. The firm's subsidiaries include Dosecann LD Inc., Kolab Project Inc., Robinson's Cannabis Inc., Robinson's Outdoor Grow Inc. and Inverell S.A.
See Also
ROE is calculated by dividing the Net Income by the Avg Total Equity.
The current ROE for Auxly Cannabis Group Inc is 31.9%, which is above its 3-year median of -37.2%.
Over the last 3 years, Auxly Cannabis Group Inc’s ROE has increased from -78.4% to 31.9%. During this period, it reached a low of -86% on Dec 31, 2022 and a high of 31.9% on Sep 30, 2025.